BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 37899453)

  • 1. Bcl-B: an "unknown" protein of the Bcl-2 family.
    Pervushin NV; Kopeina GS; Zhivotovsky B
    Biol Direct; 2023 Oct; 18(1):69. PubMed ID: 37899453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homology modeling and docking studies of human Bcl-2L10 protein.
    Bhargavi K; Kalyan Chaitanya P; Ramasree D; Vasavi M; Murthy DK; Uma V
    J Biomol Struct Dyn; 2010 Dec; 28(3):379-91. PubMed ID: 20919753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 family proteins contribute to apoptotic resistance in lung cancer multicellular spheroids.
    Yang TM; Barbone D; Fennell DA; Broaddus VC
    Am J Respir Cell Mol Biol; 2009 Jul; 41(1):14-23. PubMed ID: 19097992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL2 family of apoptosis-related genes: functions and clinical implications in cancer.
    Thomadaki H; Scorilas A
    Crit Rev Clin Lab Sci; 2006; 43(1):1-67. PubMed ID: 16531274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy.
    Reed JC; Miyashita T; Takayama S; Wang HG; Sato T; Krajewski S; Aimé-Sempé C; Bodrug S; Kitada S; Hanada M
    J Cell Biochem; 1996 Jan; 60(1):23-32. PubMed ID: 8825412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of BCL-2 Family Proteins in Apoptosis and its Regulation by Nutrients.
    Zheng C; Liu T; Liu H; Wang J
    Curr Protein Pept Sci; 2020; 21(8):799-806. PubMed ID: 31880257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the B-cell lymphoma/leukemia 2 family in cancer.
    Davids MS; Letai A
    J Clin Oncol; 2012 Sep; 30(25):3127-35. PubMed ID: 22649144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members.
    Hogg SJ; Newbold A; Vervoort SJ; Cluse LA; Martin BP; Gregory GP; Lefebure M; Vidacs E; Tothill RW; Bradner JE; Shortt J; Johnstone RW
    Mol Cancer Ther; 2016 Sep; 15(9):2030-41. PubMed ID: 27406984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of the interactome of Bcl-2 proteins in breast cancer at the transcriptional, mutational and structural level.
    Kønig SM; Rissler V; Terkelsen T; Lambrughi M; Papaleo E
    PLoS Comput Biol; 2019 Dec; 15(12):e1007485. PubMed ID: 31825969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the roles of antiapoptotic members of the Bcl-2 family in melanoma progression and therapy.
    Trisciuoglio D; Del Bufalo D
    Drug Discov Today; 2021 May; 26(5):1126-1135. PubMed ID: 33545382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting BCL-2 regulated apoptosis in cancer.
    Campbell KJ; Tait SWG
    Open Biol; 2018 May; 8(5):. PubMed ID: 29769323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptotic blocks and chemotherapy resistance: strategies to identify Bcl-2 protein signatures.
    Gul O; Basaga H; Kutuk O
    Brief Funct Genomic Proteomic; 2008 Jan; 7(1):27-34. PubMed ID: 18283052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 family gene products in cerebral ischemia and traumatic brain injury.
    Graham SH; Chen J; Clark RS
    J Neurotrauma; 2000 Oct; 17(10):831-41. PubMed ID: 11063051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2/p62 signaling in apoptosis resistance and its role in cadmium-induced carcinogenesis.
    Son YO; Pratheeshkumar P; Roy RV; Hitron JA; Wang L; Zhang Z; Shi X
    J Biol Chem; 2014 Oct; 289(41):28660-75. PubMed ID: 25157103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiapoptotic Bcl-2 protein as a potential target for cancer therapy: A mini review.
    Jagani H; Kasinathan N; Meka SR; Josyula VR
    Artif Cells Nanomed Biotechnol; 2016 Aug; 44(5):1212-21. PubMed ID: 25801037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-xL as an antiapoptotic molecule for cardiomyocytes.
    Ogata Y; Takahashi M
    Drug News Perspect; 2003 Sep; 16(7):446-52. PubMed ID: 14668940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cell death and specifics of its regulation in tumour cells].
    Belushkina NN; Khomiakova TI; Khomiakov IuN
    Ross Fiziol Zh Im I M Sechenova; 2009 Oct; 95(10):1093-107. PubMed ID: 19957898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current strategies to target the anti-apoptotic Bcl-2 protein in cancer cells.
    Osford SM; Dallman CL; Johnson PW; Ganesan A; Packham G
    Curr Med Chem; 2004 Apr; 11(8):1031-9. PubMed ID: 15083809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Apoptosis by the Bcl-2 Family of Proteins: Field on a Brink.
    Ladokhin AS
    Cells; 2020 Sep; 9(9):. PubMed ID: 32961920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells.
    Sharma A; Singh K; Mazumder S; Hill BT; Kalaycio M; Almasan A
    Cell Death Dis; 2013 May; 4(5):e628. PubMed ID: 23681223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.